Form 4: Agilon Health Executive Benjamin Shaker Reports Stock Transactions

Benjamin Shaker, Chief Markets Officer at Agilon Health, reports acquisition and disposal of company stock and stock options.

Summary

• Benjamin Shaker, Chief Markets Officer of Agilon Health, reported transactions involving the company's stock.
• On April 15, 2024, Shaker acquired 196,189 shares of common stock at $0, resulting in a total holding of 454,921 shares.
• This includes restricted stock units.
• On April 14, 2024, 5,506 shares were disposed of at $4.95 to cover income tax withholding obligations, reducing the holding to 449,415 shares.
• Shaker also acquired 322,879 options with an exercise price of $4.46, vesting in four equal installments starting April 15, 2024.
• These options expire on April 15, 2034.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing primarily reports transactions without indicating a clear positive or negative outlook. The acquisition is balanced by the disposal for tax purposes.

Positives

• The acquisition of 196,189 shares by a company executive could be seen as a positive signal.

Negatives

• The disposal of 5,506 shares, even for tax obligations, could be interpreted negatively by some investors.

Risks

• Executive stock transactions are subject to scrutiny and can be influenced by various factors, including personal financial planning and company performance.
• Changes in employment status could affect the vesting of restricted stock units and options.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into insider transactions, allowing investors to monitor the buying and selling activities of company executives and directors.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company executives as an indicator of confidence in the company's future prospects.

Key Dates